Senseonics Holdings, Inc. (AMEX:SENS) Q1 2024 Earnings Call Transcript
Q1 2024 Earnings Call Transcript May 13, 2024 Operator: Good afternoon, everyone, and welcome to the Senseonics First Quarter ...
Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitor (CGM) systems for people ...
drugdeliverybusiness11d
Senseonics, Rimidi partner on remote diabetes monitoring program
Senseonics announced today that it entered into a strategic partnership with Rimidi to develop a remote patient monitoring ...
TMCnet12d
Senseonics Partners with Rimidi to Develop Innovative Diabetes Solution
Senseonics, in collaboration with its commercial partner, Ascensia Diabetes Care, intends to make the Eversense CGM+RPM solution available to select population health-based systems beginning in the ...
Yahoo Finance22d
Eversense® CGM System Receives iCGM Designation by the US FDA
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system GERMANTOWN, Md. & PARSIPPANY, N.J., April 30, 2024 ...
drugdeliverybusiness22d
Senseonics wins integrated CGM designation from FDA, can work with insulin pumps
The Eversense E3 implantable CGM system. [Image from Ascensia/Senseonics] The FDA today granted integrated CGM (iCGM) designation to the Eversense continuous glucose monitoring system from Senseonics ...